Unknown

Dataset Information

0

Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder.


ABSTRACT: Although there have been a number of clinical trials evaluating treatments for adolescents with major depressive disorder (MDD), the generalizability of those trials to samples of depressed adolescents who present for routine clinical care is unknown. Examining the generalizability of clinical trials of pharmacological and psychotherapy interventions for adolescent depression can help administrators and frontline practitioners determine the relevance of these studies for their patients and may also guide eligibility criteria for future clinical trials in this clinical population.Data on nationally representative adolescents were derived from the National Comorbidity Survey: Adolescent Supplement. To assess the generalizability of adolescent clinical trials for MDD, we applied a standard set of eligibility criteria representative of clinical trials to all adolescents in the National Comorbidity Survey: Adolescent Supplement with a Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition diagnosis of MDD (N = 592).From the overall MDD sample, 61.9% would have been excluded from a typical pharmacological trial, whereas 42.2% would have been excluded from a psychotherapy trial. Among those who sought treatment (n = 412), the corresponding exclusion rates were 72.7% for a pharmacological trial and 52.2% for a psychotherapy trial. The criterion leading to the largest number of exclusions was "significant risk of suicide" in both pharmacological and psychotherapy trials.Pharmacological and, to a lesser extent, psychotherapy clinical trials likely exclude most adolescents with MDD. Careful consideration should be given to balancing eligibility criteria and internal validity with applicability in routine clinical care while ensuring patient safety.

SUBMITTER: Blanco C 

PROVIDER: S-EPMC5703774 | biostudies-other | 2017 Dec

REPOSITORIES: biostudies-other

altmetric image

Publications

Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder.

Blanco Carlos C   Hoertel Nicolas N   Franco Silvia S   Olfson Mark M   He Jian-Ping JP   López Saioa S   González-Pinto Ana A   Limosin Frédéric F   Merikangas Kathleen R KR  

Pediatrics 20171102 6


<h4>Background</h4>Although there have been a number of clinical trials evaluating treatments for adolescents with major depressive disorder (MDD), the generalizability of those trials to samples of depressed adolescents who present for routine clinical care is unknown. Examining the generalizability of clinical trials of pharmacological and psychotherapy interventions for adolescent depression can help administrators and frontline practitioners determine the relevance of these studies for their  ...[more]

Similar Datasets

2022-11-17 | GSE217811 | GEO
2011-10-04 | E-GEOD-19738 | biostudies-arrayexpress
| S-EPMC8589647 | biostudies-literature
2011-10-05 | GSE19738 | GEO
2012-04-27 | E-GEOD-37579 | biostudies-arrayexpress
| S-EPMC10472268 | biostudies-literature
| S-EPMC11376036 | biostudies-literature
| S-EPMC5513031 | biostudies-literature
| S-EPMC6459143 | biostudies-literature
| S-EPMC4457500 | biostudies-literature